Synthetic chromatin engineering for STAT1 reactivation toward restoring cisplatin sensitivity in breast cancer
I.-G. Park, M. Kwon, T. h. Yoo, Ji Min Lee
This study reactivates STAT1 in cisplatin-resistant breast cancer using synthetic chromatin engineering, restoring cisplatin sensitivity through enhanced nuclear translocation and transcriptional activation.
bioRxiv · Nov 9, 2026 · PreprintCancer Biology